首页 > 最新文献

Ophthalmology最新文献

英文 中文
True Duplication of the Optic Nerve. 视神经真性复制
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-10-01 DOI: 10.1016/j.ophtha.2024.08.031
Natalie Chen, Michael Balas, Parnian Arjmand
{"title":"True Duplication of the Optic Nerve.","authors":"Natalie Chen, Michael Balas, Parnian Arjmand","doi":"10.1016/j.ophtha.2024.08.031","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.031","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparities in Amblyopia Treatment Outcomes: The Impact of Sociodemographic Factors, Treatment Compliance, and Age of Diagnosis. 弱视治疗结果的差异:社会人口因素、治疗依从性和诊断年龄的影响。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-23 DOI: 10.1016/j.ophtha.2024.09.021
Kate Matsunaga, Archeta Rajagopalan, Sudha Nallasamy, Angeline Nguyen, Alexander de Castro-Abeger, Mark S Borchert, Melinda Y Chang

Purpose: To identify clinical and sociodemographic factors associated with disparities in amblyopia treatment outcomes.

Design: Retrospective chart review.

Participants: Children ≤ 8 years of age diagnosed and treated for unilateral refractive or strabismic amblyopia at our institution from 2012 to 2022.

Methods: Children with amblyopia were categorized by outcome: resolved amblyopia (< 0.2 logarithm of the minimum angle of resolution [logMAR] interocular difference [IOD] in visual acuity [VA] or no fixation preference in nonverbal patients) or persistent amblyopia. Demographic and clinical data were recorded from the medical record. Zip codes were used to calculate Childhood Opportunity Index (COI) scores, estimated annual household income, and distance to hospital.

Main outcome measures: Sociodemographic and clinical factors were compared between children with resolved and persistent amblyopia. Factors significant at P < 0.10 on univariate analysis were included in a multivariable regression model.

Results: A total of 168 patients met inclusion criteria, and 131 patients (78%) had resolved amblyopia. Demographic factors associated with resolution of amblyopia were younger age at diagnosis (3.3 ± 1.7 years vs. 4.5 ± 1.9 years; P = 0.0009), English as the primary language (79.4% vs. 62.2%; P = 0.04), higher estimated annual income ($83 315.93 ± $29 276.64 vs. $71 623.00 ± $26 842.56; P = 0.03), higher COI scores (50.9 ± 27.3 vs. 40.0 ± 26.4; P = 0.03), and living farther from our institution (28.6 ± 37.6 miles vs. 14.9 ± 12.7 miles; P = 0.003). Patients with resolved amblyopia also had higher rates of treatment compliance (83.2% ± 25.0% vs. 75.6% ± 24.4%; P = 0.009) and shorter delays in follow-up (40.1 ± 76.8 days vs. 61.1 ± 90.4 days; P = 0.02). Amblyopia persistence was borderline associated with governmental insurance and higher presenting IOD in VA (both P = 0.06). On multivariate analysis, only younger age at amblyopia diagnosis (P = 0.0010) remained significantly associated with amblyopia resolution.

Conclusions: Our findings suggest that disparities in amblyopia outcomes are related to differences in age at diagnosis. Interventions to lower the age at which amblyopia is diagnosed, such as programs to improve vision screening rates and access to pediatric eye care in at-risk groups, may directly address inequities in rates of amblyopia resolution.

Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.

目的: 确定与弱视治疗效果差异相关的临床和社会人口因素:确定与弱视治疗结果差异相关的临床和社会人口因素:研究对象2012年至2022年期间,在我院诊断并治疗单侧屈光性或斜视性弱视的8岁以下儿童:方法:将弱视儿童按结果分类:弱视缓解(主要结果测量:比较弱视缓解和弱视持续的儿童的社会人口学和临床因素。结果168名患者符合纳入标准,其中131名(78%)弱视得到缓解。与弱视缓解相关的人口统计学因素有:诊断时年龄较小(3.3±1.7 岁 vs. 4.5±1.9岁,p=0.0009)、英语为主要语言(79.4% vs. 62.2%,p=0.04)、估计年收入较高($83,315.93±29,276.64 美元 vs. 71,623.00±26,842.56 美元,P=0.03),COI 评分更高(50.9±27.3 vs. 40.0±26.4,P=0.03),居住地离本机构更远(28.6±37.6 vs. 14.9±12.7 英里,P=0.003)。弱视缓解患者的治疗依从性更高(83.2±25.0% vs. 75.6±24.4%,p=0.009),随访延迟时间更短(40.1±76.8 vs. 61.1±90.4天,p=0.02)。弱视持续与政府保险和较高的视力IOD呈边缘相关(均为p=0.06)。在多变量分析中,只有弱视诊断年龄较小(p=0.0010)与弱视缓解仍有显著相关性:我们的研究结果表明,弱视结果的差异与诊断年龄的差异有关。降低弱视诊断年龄的干预措施,如提高视力筛查率和改善高危人群接受儿科眼科治疗的机会,可直接解决弱视矫正率不平等的问题。
{"title":"Disparities in Amblyopia Treatment Outcomes: The Impact of Sociodemographic Factors, Treatment Compliance, and Age of Diagnosis.","authors":"Kate Matsunaga, Archeta Rajagopalan, Sudha Nallasamy, Angeline Nguyen, Alexander de Castro-Abeger, Mark S Borchert, Melinda Y Chang","doi":"10.1016/j.ophtha.2024.09.021","DOIUrl":"10.1016/j.ophtha.2024.09.021","url":null,"abstract":"<p><strong>Purpose: </strong>To identify clinical and sociodemographic factors associated with disparities in amblyopia treatment outcomes.</p><p><strong>Design: </strong>Retrospective chart review.</p><p><strong>Participants: </strong>Children ≤ 8 years of age diagnosed and treated for unilateral refractive or strabismic amblyopia at our institution from 2012 to 2022.</p><p><strong>Methods: </strong>Children with amblyopia were categorized by outcome: resolved amblyopia (< 0.2 logarithm of the minimum angle of resolution [logMAR] interocular difference [IOD] in visual acuity [VA] or no fixation preference in nonverbal patients) or persistent amblyopia. Demographic and clinical data were recorded from the medical record. Zip codes were used to calculate Childhood Opportunity Index (COI) scores, estimated annual household income, and distance to hospital.</p><p><strong>Main outcome measures: </strong>Sociodemographic and clinical factors were compared between children with resolved and persistent amblyopia. Factors significant at P < 0.10 on univariate analysis were included in a multivariable regression model.</p><p><strong>Results: </strong>A total of 168 patients met inclusion criteria, and 131 patients (78%) had resolved amblyopia. Demographic factors associated with resolution of amblyopia were younger age at diagnosis (3.3 ± 1.7 years vs. 4.5 ± 1.9 years; P = 0.0009), English as the primary language (79.4% vs. 62.2%; P = 0.04), higher estimated annual income ($83 315.93 ± $29 276.64 vs. $71 623.00 ± $26 842.56; P = 0.03), higher COI scores (50.9 ± 27.3 vs. 40.0 ± 26.4; P = 0.03), and living farther from our institution (28.6 ± 37.6 miles vs. 14.9 ± 12.7 miles; P = 0.003). Patients with resolved amblyopia also had higher rates of treatment compliance (83.2% ± 25.0% vs. 75.6% ± 24.4%; P = 0.009) and shorter delays in follow-up (40.1 ± 76.8 days vs. 61.1 ± 90.4 days; P = 0.02). Amblyopia persistence was borderline associated with governmental insurance and higher presenting IOD in VA (both P = 0.06). On multivariate analysis, only younger age at amblyopia diagnosis (P = 0.0010) remained significantly associated with amblyopia resolution.</p><p><strong>Conclusions: </strong>Our findings suggest that disparities in amblyopia outcomes are related to differences in age at diagnosis. Interventions to lower the age at which amblyopia is diagnosed, such as programs to improve vision screening rates and access to pediatric eye care in at-risk groups, may directly address inequities in rates of amblyopia resolution.</p><p><strong>Financial disclosure(s): </strong>Proprietary or commercial disclosure may be found after the references.</p>","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extranodal Rosai-Dorfman Disease Presenting as a Rapidly Enlarging Limbal Mass. 外结节性罗赛-多夫曼病表现为迅速增大的肢端肿块
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-20 DOI: 10.1016/j.ophtha.2024.08.019
Lauren B Yeager, Craig R Soderquist, Brian P Marr
{"title":"Extranodal Rosai-Dorfman Disease Presenting as a Rapidly Enlarging Limbal Mass.","authors":"Lauren B Yeager, Craig R Soderquist, Brian P Marr","doi":"10.1016/j.ophtha.2024.08.019","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.019","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral Hypopyon: Iris Metastasis of Urothelial Carcinoma. 单侧眼睑下垂尿路上皮癌的虹膜转移
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-20 DOI: 10.1016/j.ophtha.2024.08.026
Yasumasa Kishi, Tomona Hiyama, Yosuke Harada
{"title":"Unilateral Hypopyon: Iris Metastasis of Urothelial Carcinoma.","authors":"Yasumasa Kishi, Tomona Hiyama, Yosuke Harada","doi":"10.1016/j.ophtha.2024.08.026","DOIUrl":"https://doi.org/10.1016/j.ophtha.2024.08.026","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":" ","pages":""},"PeriodicalIF":13.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Council of Vision Editors Fellowship Program 视觉编辑理事会奖学金计划。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.ophtha.2024.07.029
Russell N. Van Gelder MD, PhD
{"title":"The Council of Vision Editors Fellowship Program","authors":"Russell N. Van Gelder MD, PhD","doi":"10.1016/j.ophtha.2024.07.029","DOIUrl":"10.1016/j.ophtha.2024.07.029","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":"131 10","pages":"Pages 1143-1144"},"PeriodicalIF":13.1,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue at a Glance 问题概览
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.ophtha.2024.08.011
Sandeep Ravindran PhD
{"title":"Issue at a Glance","authors":"Sandeep Ravindran PhD","doi":"10.1016/j.ophtha.2024.08.011","DOIUrl":"10.1016/j.ophtha.2024.08.011","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":"131 10","pages":"Page e3"},"PeriodicalIF":13.1,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the Realm of Claims-Based Research 驾驭以索赔为基础的研究领域。
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.ophtha.2024.05.016
Catherine Q. Sun MD, Nisha R. Acharya MD
{"title":"Navigating the Realm of Claims-Based Research","authors":"Catherine Q. Sun MD,&nbsp;Nisha R. Acharya MD","doi":"10.1016/j.ophtha.2024.05.016","DOIUrl":"10.1016/j.ophtha.2024.05.016","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":"131 10","pages":"Pages 1139-1142"},"PeriodicalIF":13.1,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142292789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
This Issue at a Glance 本期概览
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.ophtha.2024.08.006
Sandeep Ravindran PhD
{"title":"This Issue at a Glance","authors":"Sandeep Ravindran PhD","doi":"10.1016/j.ophtha.2024.08.006","DOIUrl":"10.1016/j.ophtha.2024.08.006","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":"131 10","pages":"Page 1133"},"PeriodicalIF":13.1,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
This Issue at a Glance 本期概览
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.ophtha.2024.08.014
Sandeep Ravindran PhD
{"title":"This Issue at a Glance","authors":"Sandeep Ravindran PhD","doi":"10.1016/j.ophtha.2024.08.014","DOIUrl":"10.1016/j.ophtha.2024.08.014","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":"131 10","pages":"Pages F1-F42"},"PeriodicalIF":13.1,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
En Breve 书信
IF 13.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-09-19 DOI: 10.1016/j.ophtha.2024.08.020
Sandeep Ravindran PhD
{"title":"En Breve","authors":"Sandeep Ravindran PhD","doi":"10.1016/j.ophtha.2024.08.020","DOIUrl":"10.1016/j.ophtha.2024.08.020","url":null,"abstract":"","PeriodicalId":19533,"journal":{"name":"Ophthalmology","volume":"131 10","pages":"Pages e1-e2"},"PeriodicalIF":13.1,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1